Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

America Great Health

Healthcare US AAGH

0.0002USD
0.00(0%)

Last update at 2026-06-23T20:00:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

0.00010.0057
LowHigh

Fundamentals

  • Previous Close 0.0002
  • Market Cap2.12M
  • Volume500
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.36815M
  • Revenue TTM0.39M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.34M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -1.22636M -0.77734M -0.77734M -0.26905M -0.05112M
Minority interest 0.00212M 0.00579M 0.02M 0.06M -
Net income -1.22057M -0.76142M -0.76142M -0.26905M -0.05192M
Selling general administrative 0.86M 0.66M 0.66M 0.29M 0.05M
Selling and marketing expenses 0.10M 0.00400M 0.00400M 0.09M -
Gross profit 0.17M 0.17M 0.17M 0.05M 0.00211M
Reconciled depreciation 0.01M 0.01M 0.01M 0.00590M -
Ebit -0.78264M -0.45764M -0.45764M -0.24356M -0.04677M
Ebitda -0.76785M -0.44729M -0.44729M -0.24901M -0.04615M
Depreciation and amortization 0.01M 0.01M 0.01M -0.00545M -0.00097M
Non operating income net other - - - - -0.01298M
Operating income -0.78270M -0.49264M -0.49264M -0.24356M -0.04615M
Other operating expenses 1.08M 0.70M 0.70M 0.44M 0.05M
Interest expense 0.44M 0.32M 0.32M 0.02M 0.00496M
Tax provision - - - - 0.00000M
Interest income 0.00005M 0.00006M 0.00003M 0.00001M -
Net interest income -0.33831M -0.44366M -0.31968M -0.19091M -0.02004M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.34M 0.34M 0.02M 0.00080M
Total revenue 0.29M 0.20M 0.20M 0.20M 0.00547M
Total operating expenses 0.95M 0.66M 0.66M 0.29M 0.05M
Cost of revenue 0.12M 0.04M 0.04M 0.14M 0.00337M
Total other income expense net -0.44366M -0.28470M 0.03M -0.02549M -0.00496M
Discontinued operations - - - - -
Net income from continuing ops -0.72124M -1.22636M -0.77734M -4.92494M -0.05192M
Net income applicable to common shares - - -0.76142M -4.86615M -0.05192M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 0.32M 0.30M 0.30M 0.62M 0.00389M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.03M 0.02M 0.02M 0.02M 0.00259M
Total liab 5.64M 4.82M 4.82M 1.09M 0.22M
Total stockholder equity -5.23111M -4.52584M -4.45113M -0.46783M -0.21501M
Deferred long term liab - - - - -
Other current liab 1.47M 0.67M 0.67M 0.32M 0.17M
Common stock - - - - -
Capital stock 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Retained earnings -10.24868M -9.18311M -9.18311M -3.55570M -3.28664M
Other liab - - 0.61M 0.38M -
Good will - - - - -
Other assets - - 0.02M 0.02M 0.00070M
Cash 0.05M 0.05M 0.05M 0.40M 0.00017M
Cash and equivalents - - - - -
Total current liabilities 3.59M 3.09M 3.09M 0.43M 0.22M
Current deferred revenue 0.06M 0.22M 0.22M 0.16M -
Net debt 2.43M 1.82M 1.82M 0.31M -0.00017M
Short term debt 0.63M 0.75M 0.75M 0.05M -
Short long term debt 0.60M 0.61M 0.71M 0.18M -
Short long term debt total 2.48M 1.87M 1.87M 0.71M -
Other stockholder equity 5.02M 4.73M 4.73M 3.09M 3.07M
Property plant equipment - - 0.10M 0.12M 0.14M
Total current assets 0.23M 0.18M 0.18M 0.48M 0.00389M
Long term investments - - - - -
Net tangible assets - - -4.45113M -3.80170M -0.21501M
Short term investments - - - - -
Net receivables 0.06M 0.06M 0.00000M 0.06M 0.00259M
Long term debt 2.22M 1.83M 1.12M 1.03M 0.58M
Inventory 0.08M 0.11M 0.11M 0.00785M 0.00114M
Accounts payable 1.44M 1.45M 1.45M 0.06M 0.05M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.00148M -0.00050M -0.00050M 0.00016M -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -3.28664M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.01M 0.01M 0.02M 0.02M -
Deferred long term asset charges - - - - -
Non current assets total 0.10M 0.12M 0.12M 0.14M 0.14M
Capital lease obligations 0.03M 0.04M 0.04M 0.09M 0.13M
Long term debt total - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - 0.00000M -0.04442M -0.01685M -0.01267M
Change to liabilities - - 0.08M 1.54M 0.01M
Total cashflows from investing activities - -0.04442M -0.04442M -0.01685M -0.01267M
Net borrowings 0.14M -0.11447M 0.70M 1.07M 0.04M
Total cash from financing activities 0.62M 0.79M 0.79M 0.74M 0.04M
Change to operating activities - - -0.09432M 0.51M -0.01760M
Net income -1.22636M -0.76142M -0.77734M -0.26905M -0.05192M
Change in cash 0.00079M -0.00849M -0.00849M 0.40M 0.00006M
Begin period cash flow 0.05M 0.06M 0.06M 0.00017M 0.00010M
End period cash flow 0.05M 0.05M 0.05M 0.40M 0.00017M
Total cash from operating activities -0.61563M -0.75290M -0.75290M -0.32924M -0.03956M
Issuance of capital stock 0.10M 0.12M 0.09M 0.10M -
Depreciation 0.01M 0.01M 0.01M 0.00590M 0.00590M
Other cashflows from investing activities - - - - -
Dividends paid 0.00000M 0.00000M - - -
Change to inventory 0.02M 0.00771M 0.00771M -0.00671M -0.00114M
Change to account receivables -0.05510M 0.00092M 0.00092M -0.00092M -0.05855M
Sale purchase of stock - - - - -
Other cashflows from financing activities 0.62M -0.14872M 0.70M 0.74M 0.04M
Change to netincome - - -0.01072M 1.31M 0.01M
Capital expenditures 0.00000M 0.04M 0.04M 0.01M 0.01M
Change receivables - - - - -0.00259M
Cash flows other operating - - - - 0.00491M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - 0.00006M
Change in working capital 0.50M -0.08569M -0.00631M -0.07572M 0.00745M
Stock based compensation 0.12M 0.07M 0.00000M 0.00206M 0.00206M
Other non cash items -0.02304M -0.05530M 0.02M 0.01M 0.00491M
Free cash flow -0.61563M -0.79732M -0.79732M -0.34191M -0.03956M

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AAGH
America Great Health		 - -% 0.0002 - - 5.40 358698.71 12.41 -56.0273
NVO
Novo Nordisk A/S		 0.03 0.05% 47.45 41.58 31.15 2.13 32.99 2.11 4.70
NONOF
Novo Nordisk A/S		 1.16 2.48% 48.00 41.06 31.25 2.08 33.11 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc		 8.43 1.80% 476.85 29.67 24.33 10.38 5.83 9.33 20.00
REGN
Regeneron Pharmaceuticals Inc		 7.92 1.28% 625.95 29.07 20.12 7.57 3.82 6.95 19.42

Reports Covered

Stock Research & News

View All

Profile

America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and nutritional dietary supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health is based in Alhambra, California.

America Great Health

1609 W. Valley Blvd., Alhambra, CA, United States, 91803

Key Executives

Name Title Year Born
Mr. Mike Qingkun Wang CEO, Pres, CFO, Sec. & Chairman 1955
Mr. Qinghua Chen CPA, CPA Chief Financial Officer 1963
Mr. David Liu Chief Operating Officer NA
David Tsai Chief Scientist NA
Mr. Mike Qingkun Wang CEO, President, CFO, Secretary & Chairman of the Board 1955

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions